Abstract
Nocturnal enuresis can be frustrating for children and their families as the child ages, but clinical intervention generally is not warranted until the child is 5 to 7 years old. If nocturnal enuresis is left untreated, resolving the problem can become more difficult. A diagnosis of nocturnal enuresis requires careful coordination of both the patient and the family for optimal outcomes and to avoid relapse. Many treatment plans are founded on motivational therapy and enuresis alarms. Desmopressin and imipramine are FDA-approved for the treatment of nocturnal enuresis in patients older than 6 years. Use of these medications requires thorough counseling by a pharmacist to ensure that the family understands that these medications cannot cure nocturnal enuresis, but are used only for symptom treatment.
| Original language | English (US) |
|---|---|
| Pages | 32-35 |
| Number of pages | 4 |
| Volume | 42 |
| No | 5 |
| Specialist publication | U.S. Pharmacist |
| State | Published - May 1 2017 |
Fingerprint
All Science Journal Classification (ASJC) codes
- Pharmacy
- Pharmacology
- Pharmaceutical Science
Cite this
Bed-wetting : Approaches to nocturnal enuresis in children. / Scheffel, Elizabeth C.; DeSimone, Edward M.; Davidian, Michael H.
In: U.S. Pharmacist, Vol. 42, No. 5, 01.05.2017, p. 32-35.Research output: Contribution to specialist publication › Article
}
TY - GEN
T1 - Bed-wetting
T2 - Approaches to nocturnal enuresis in children
AU - Scheffel, Elizabeth C.
AU - DeSimone, Edward M.
AU - Davidian, Michael H.
PY - 2017/5/1
Y1 - 2017/5/1
N2 - Nocturnal enuresis can be frustrating for children and their families as the child ages, but clinical intervention generally is not warranted until the child is 5 to 7 years old. If nocturnal enuresis is left untreated, resolving the problem can become more difficult. A diagnosis of nocturnal enuresis requires careful coordination of both the patient and the family for optimal outcomes and to avoid relapse. Many treatment plans are founded on motivational therapy and enuresis alarms. Desmopressin and imipramine are FDA-approved for the treatment of nocturnal enuresis in patients older than 6 years. Use of these medications requires thorough counseling by a pharmacist to ensure that the family understands that these medications cannot cure nocturnal enuresis, but are used only for symptom treatment.
AB - Nocturnal enuresis can be frustrating for children and their families as the child ages, but clinical intervention generally is not warranted until the child is 5 to 7 years old. If nocturnal enuresis is left untreated, resolving the problem can become more difficult. A diagnosis of nocturnal enuresis requires careful coordination of both the patient and the family for optimal outcomes and to avoid relapse. Many treatment plans are founded on motivational therapy and enuresis alarms. Desmopressin and imipramine are FDA-approved for the treatment of nocturnal enuresis in patients older than 6 years. Use of these medications requires thorough counseling by a pharmacist to ensure that the family understands that these medications cannot cure nocturnal enuresis, but are used only for symptom treatment.
UR - http://www.scopus.com/inward/record.url?scp=85019835040&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85019835040&partnerID=8YFLogxK
M3 - Article
AN - SCOPUS:85019835040
VL - 42
SP - 32
EP - 35
JO - U.S. Pharmacist
JF - U.S. Pharmacist
SN - 0148-4818
ER -